AI CuratorAI-generated

Research summary · 3 d ago

AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

CSF Biomarkers in MS Diagnosis Using T2-Hyperintense Lesion Samples

In a study analyzing 62 cerebrospinal fluid (CSF) samples from suspected MS patients, levels of neurofilament light chain (NfL) and CHI3L1 were significantly elevated compared to a non-MS group. The presence of oligoclonal bands (OCBs) showed excellent diagnostic utility for MS, with an area under the curve (AUC) of 0.978. In contrast, NfL and CHI3L1 had lower AUCs of 0.729 and 0.838, respectively.

Tags: #MSResearch
Most relevant to: —
Source: Read original source (PMID 42833333)

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

These findings highlight the potential of CSF biomarkers, particularly OCBs, in distinguishing MS from non-MS conditions, which could improve diagnostic accuracy. However, reliance on only biomarker analysis limits understanding of broader clinical implications and long-term outcomes.

What this does not prove

The study did not assess the clinical context or the long-term outcomes associated with the biomarker levels, limiting its applicability and understanding of MS diagnosis and management.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Not reported
Participants / samples: 62 · CSF samples collected from suspected MS patients with T2-Hyperintense lesions
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: 2026-10-05
Evidence reviewed: Abstract only
Regulatory approval: Not reported
Research areas: Not classified

Original sources

Primary evidenceComparative diagnostic utility of cerebrospinal fluid biomarkers in multiple sclerosis. ↗DOI: 10.1016/j.cca.2026.122872

Supporting passages (7)

sample size62

sample size basisMETHODS: We collected 62 CSF samples from suspected MS patients with T2-Hyperintense lesions and investigated OCBs and enzyme-linked immunosorbent assay (ELISA) for NfL, CHI3L1, and GFAP.

publication date2026-10-05

comparatornon-MS group

findingsRESULTS: The CSF levels of NfL (p < 0.001) and CHI3L1 (p < 0.001) were significantly elevated in the MS group compared to the non-MS group, in contrast to GFAP (p = 0.17).

findingsDiagnostic criteria for MS diagnosis was excellent for OCBs (Area under curve (AUC) = 0.978, p < 0.001; 95% Confidence Interval (CI): 0.929-1.000), good for CHI3L1 (AUC = 0.838, p < 0.001; 95% CI: 0.738-0.939), acceptable for NfL (AUC = 0.729, p = 0.003; 95% CI: 0.602-0.855) and poor for GFAP (AUC = 0.604, p = 0.173; 95% CI: 0.477-0.762).

limitationsTitle: Comparative diagnostic utility of cerebrospinal fluid biomarkers in multiple sclerosis.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.